Literature DB >> 15876165

Celiac disease presenting as resistant hypothyroidism.

J H McDermott1, A Coss, C H Walsh.   

Abstract

The high prevalence of celiac disease in patients with autoimmune hypothyroidism, compared to the general population, has been well documented but screening for celiac disease is not recommended as yet in otherwise asymptomatic hypothyroid patients. In recent years the high prevalence of undiagnosed celiac disease in the general population, largely as a result of the many atypical manifestations of the disease, has become apparent. We report the case of a 58-year-old woman with autoimmune hypothyroidism who was initially suspected of having celiac disease on the basis of apparent resistance to levothyroxine therapy, and who had no other clinical or laboratory clues to suggest the diagnosis. Cases of undiagnosed celiac disease causing levothyroxine malabsorbtion have previously been described, but all previous cases had other obvious manifestations of the disease. We believe that this atypical presentation of celiac disease warrants further attention, and that the diagnosis of celiac disease should always be considered in patients requiring higher than expected doses of thyroid hormone replacement, even in patients with normal bowel habit, and no other apparent manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876165     DOI: 10.1089/thy.2005.15.386

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Occurrence of overt celiac disease in the elderly following total thyroidectomy.

Authors:  M Caputo; R Brizzolara; M Schiavo; C Salmaso; G Pesce; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

3.  Intestinal absorption and buccal absorption of liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari
Journal:  Endocrine       Date:  2017-03-07       Impact factor: 3.633

4.  Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Santino Marchi; Nicola De Bortoli; Ilaria Ruffilli; Alessandro Antonelli
Journal:  Endocrine       Date:  2016-08-30       Impact factor: 3.633

5.  Best Time for Levothyroxine Intake in Ramadan (THYRAM): Basrah Experience.

Authors:  Ibrahim Abbood Zaboon; Haider Ayad Alidrisi; Ibrahim Hani Hussein; Majid Alabbood; Nassar Taha Yaseen Alibrahim; Ammar Mohammed Saeed Almomin; Dheyaa Kadhim Al-Waeli; Ali Hussein Ali Alhamza; Adel Gassab Mohammed; Hussein Ali Nwayyir; Ahmed Jaafer Hindi Al-Ali; Abbas Ali Mansour
Journal:  Int J Endocrinol Metab       Date:  2020-04-06

6.  TSH-Suppressive Therapy: A Thorny Issue.

Authors:  Itala Marina Baldini; Cristina Cocino; Sonia Seghezzi; Maria Domenica Cappellini
Journal:  Eur J Case Rep Intern Med       Date:  2017-03-27

Review 7.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.